Asressu, K.H.; Smith, J.L.; Dickmander, R.J.; Moorman, N.J.; Wellnitz, J.; Popov, K.I.; Axtman, A.D.; Willson, T.M.
Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity. Pharmaceuticals 2024, 17, 306.
https://doi.org/10.3390/ph17030306
AMA Style
Asressu KH, Smith JL, Dickmander RJ, Moorman NJ, Wellnitz J, Popov KI, Axtman AD, Willson TM.
Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity. Pharmaceuticals. 2024; 17(3):306.
https://doi.org/10.3390/ph17030306
Chicago/Turabian Style
Asressu, Kesatebrhan Haile, Jeffery L. Smith, Rebekah J. Dickmander, Nathaniel J. Moorman, James Wellnitz, Konstantin I. Popov, Alison D. Axtman, and Timothy M. Willson.
2024. "Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity" Pharmaceuticals 17, no. 3: 306.
https://doi.org/10.3390/ph17030306
APA Style
Asressu, K. H., Smith, J. L., Dickmander, R. J., Moorman, N. J., Wellnitz, J., Popov, K. I., Axtman, A. D., & Willson, T. M.
(2024). Synthesis of 5-Benzylamino and 5-Alkylamino-Substituted Pyrimido[4,5-c]quinoline Derivatives as CSNK2A Inhibitors with Antiviral Activity. Pharmaceuticals, 17(3), 306.
https://doi.org/10.3390/ph17030306